Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Acq. announced
Quarterly results
Director departure
Appointed director
Inv. presentation
Auditor change
CC transcript

QUESTCOR PHARMACEUTICALS INC (QCOR) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/20/2014 8-K Form 8-K - Current report
08/18/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
08/18/2014 4 Furey Raymond J. (See Remarks) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
08/18/2014 4 SILVERMAN LOU (Director) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
08/18/2014 4 BAILEY DON M (See Remarks) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
08/18/2014 4 Cartt Stephen LaHue (COO) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
08/18/2014 4 Medeiros David Jeffrey (EVP and CTO) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
08/18/2014 4 Whitcup Scott M (Director) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
08/18/2014 4 FARRELL STEPHEN C (Director) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
08/18/2014 4 Martin G. Kelly (Director) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
Txns: Disposed/sold 2,812 shares @ $0
Disposed/sold 1,160 options to buy @ $61.598, valued at $71.5k
08/18/2014 4 Asarpota Rajesh (Sr. VP., CFO and PAO) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
Txns: Disposed/sold 20,000 shares @ $0
Disposed/sold 4,000 shares @ $0
08/18/2014 4 THOMPSON VIRGIL D (Director) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
08/18/2014 4 Mulroy Michael H. (EVP, Strat. Affairs & GC) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
08/18/2014 4 Russell Angus C. (Director) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
Txns: Disposed/sold 4,529 shares @ $0
Disposed/sold 3,835 shares @ $0
Disposed/sold 3,281 options to buy @ $36.29, valued at $119.1k
08/18/2014 4 BROADWOOD PARTNERS LP (Director) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
Txns: Disposed of 1,818,248 shares @ $0
Disposed/sold 11,683 shares @ $0
Disposed/sold 32,500 options to buy @ $0.53, valued at $17.2k
Disposed/sold 32,500 options to buy @ $1.04, valued at $33.8k
Disposed/sold 32,500 options to buy @ $1.47, valued at $47.8k
Disposed/sold 32,500 options to buy @ $5.77, valued at $187.5k
Disposed/sold 32,500 options to buy @ $9.31, valued at $302.6k
Disposed/sold 32,500 options to buy @ $4.75, valued at $154.4k
Disposed/sold 17,500 options to buy @ $14.73, valued at $257.8k
Disposed/sold 15,000 options to buy @ $14.73, valued at $221k
Disposed/sold 15,214 options to buy @ $40.37, valued at $614.2k
08/15/2014 4 BAILEY DON M (See Remarks) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
08/14/2014 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "MALLINCKRODT AND QUESTCOR SHAREHOLDERS APPROVE MALLINCKRODT'S ACQUISITION OF QUESTCOR DUBLIN, IRELAND and ANAHEIM, Calif., Aug. 14, 2014 — Mallinckrodt plc and Questcor Pharmaceuticals, Inc. today jointly announced that all proposals necessary for Mallinckrodt's acquisition of Questcor were approved by Mallinckrodt's and Questcor's shareholders at each company's respective shareholder meeting held today. As previously announced, on April 7, 2014, Mallinckrodt and Questcor entered into a definitive agreement by which Mallinckrodt will acquire Questcor. Under the terms of the transaction, Questcor shareholders will receive $30.00 in cash and 0.897 of a Mallinckrodt ordinary share for each Questcor share. Mallinckrodt expects to close the transaction later today and subsequently issue a press..."
08/13/2014 4 Mulroy Michael H. (See Remarks) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
08/11/2014 425 Form 425 - Prospectuses and communications, business combinations
08/11/2014 425 Form 425 - Prospectuses and communications, business combinations
08/11/2014 425 Form 425 - Prospectuses and communications, business combinations
08/11/2014 425 Form 425 - Prospectuses and communications, business combinations
08/11/2014 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/07/2014 425 Form 425 - Prospectuses and communications, business combinations
08/06/2014 4 BROADWOOD PARTNERS LP (Director) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
Txns: Gifted 228,412 shares @ $0
08/05/2014 425 Form 425 - Prospectuses and communications, business combinations
08/04/2014 4 Mulroy Michael H. (See Remarks) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
07/30/2014 425 Form 425 - Prospectuses and communications, business combinations
07/29/2014 8-K Other Events
07/29/2014 425 Form 425 - Prospectuses and communications, business combinations
07/29/2014 425 Form 425 - Prospectuses and communications, business combinations
07/29/2014 425 Form 425 - Prospectuses and communications, business combinations
07/28/2014 425 Form 425 - Prospectuses and communications, business combinations
07/25/2014 8-K Quarterly results
Docs: "Questcor Reports Record Second Quarter Financial Results"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy